Toll-like receptors (TLRs) are the best-characterized membrane-bound receptors in innate immune cells, including macrophages and dendritic cells. Upon recognition of specific ligands originating from pathogen-and modified selfderived molecules, TLRs trigger intracellular signaling cascades that involve various adaptor proteins and enzymes, resulting in the generation of proinflammatory and antimicrobial responses through the activation of transcription factors such as nuclear factor-κB. TLR-dependent signaling pathways are tightly regulated during innate immune responses by a variety of negative regulators. This review focuses on the newly described regulation of TLR-dependent signaling pathways, and emphasizes the roles of TLRs in innate immunity. Efforts to modulate these regulatory pathways and signaling molecules may result in the development of new therapeutic strategies through TLR-based therapy.
INTRODUCTION
The mammalian innate immune system acts as a sentinel by facilitating the efficient recognition of infectious microbes and providing protective mechanisms that eradicate microbial infections. In this context, Toll-like receptors (TLRs) are the best-characterized innate receptors, can be rapidly activated, and consist of functional modules that provide crucial host defense during microbial infection (1) In addition, a variety of regulatory factors that control TLR activation have been reported to be involved in the negative feedback of TLR-dependent signaling (7) . This coordinated activation of immune signaling pathways is required for the optimal and effective induction of host defense, eradication of invading pathogens, and maintaining cellular homeostasis. This review focuses on recent advances in our understanding of the role and regulatory mechanisms of TLR-induced signaling as it relates to innate and inflammatory responses. This issue not only has crucial implications for understanding host innate mechanisms, but also for controlling harmful inflammatory conditions.
Overview of TLR family
Toll was the first protein in the fruit fly Drosophila melanogaster to be described as a key receptor for dorsoventral polarity in the developing fly embryo, and is required for host defense against fungal infections (8) . The subsequent identification of mammalian TLRs has provided key insights into microbial pathogenesis and human protective immunology. The TLR family of innate receptors plays a critical role in recognition and effector functions during infection. To achieve this, different TLRs sense distinct conserved molecular patterns of various microorganisms, thus providing the innate immune system with a degree of specificity against different pathogens (1) . To date, 10 functional TLRs have been identified in humans and 12 in mice.
The mammalian TLR1-9 are conserved; however, mouse TLR10 is not functional, and TLR11-13 have been lost from the human genome (9) . The TLR family can be divided into extracellular and intracellular receptors: TLR1, 2, 4, 5, 6, and 10 are on the cell surface, whereas TLR3, 7, 8, and 9 are present in intracellular endosomal/lysosomal compartments and the endoplasmic reticulum (ER) (10) . Additionally, TLRs located in intracellular organelles, such as endosomal/lysosomal compartments and the endoplasmic reticulum, can recognize viral and/or synthetic nucleic acid ligands. TLR3 can recognize viral doublestranded RNA (dsRNA), which is generated by RNA viruses during infection (17) . TLR7 recognizes the imidazoquinoline family antiviral compounds imiquimod (also known as Aldara, R-837 or S-26308) and resiquimod (also known as R-848 or S-28463) (18) . Additionally, TLR7 and 8 recognize single-stranded RNA from RNA viruses (19, 20) . TLR9 recognizes non-methylated 2'-deoxyribo (cytidine-phosphate- Figure 1 . Toll-like receptor signaling pathways. Toll-like receptor (TLR) signaling is activated by stimulation of TLR ligands. TLR stimulation recruits MyD88 adaptor protein to the all TLRs except for TLR3. MyD88 interacts with a complex of the IRAKs and TRAF6 to activate the TAK1, which subsequently induces translocation of NF-κB and AP-1 to the nucleus through degradation of IκB proteins and activation of MAPKs, respectively. It leads to the expression of genes encoding the pro-inflammatory cytokines. Mal is also recruited to the TLR2/1, TLR2/6 and TLR4 to activate the MyD88-dependent pathway. TRIF protein is recruited to TLR3 and TLR4, which induces the interaction with a complex of TRAF3, TBK1 and IKKi to activate phosphorylation of IRF3. Activated IRF3 is dimerized and translocated into the nucleus, which induces protein expression of type I IFNs. TRIF also interacts with a TRAF6-RIP1 complex to activate NF-κB. TRAM is responsible for activation of TRIF-dependent pathway in TLR4, but not TLR3 signaling. Stimulation with ligands for TLR7, TLR8 and TLR9 forms a signaling complex consisting of MyD88, IRAK4, TRAF6, TRAF3, and IRAK1. TRAF6 and TRAF3 are responsible for activation of NF-κB (for proinflammatory cytokines) and IRF7 (for type I IFNs), respectively. TLR2-TLR4 double-deficient mice were more susceptible than TLR4-deficient mice, although MyD88-deficient mice were the most susceptible, when challenged with Salmonella typhimurium (36) . Other studies have shown that MyD88-deficient mice have an increased susceptibility to, and decreased cytokine responses upon acute infection with, Trypanosoma cruzi; however, TLR2-deficient mice had no major defect in parasite control (37) . In a mouse model of Clostridium difficile infection, MyD88-deficient mice had severe and often fatal intestinal disease (38) . Moreover, TLR5 ligation using flagellin enhances host resistance to C. difficile infection in vivo (39) .
Earlier studies reported that TLR2-and MyD88-deficient mice exhibit an increased susceptibility and bacterial burden in the kidneys and blood after systemic infection with Staphylococcus aureus (S. aureus) (40) . MyD88-deficient macrophages did not produce cytokines in response to S. aureus, although TLR2-deficient macrophages produced detectable cytokine levels. Both TLR2 and IL-1 are required for host protection from systemic and cutaneous S. aureus infection (41) . Generally, the phenotype of MyD88-deficient mice is more severe than that of TLR2-deficient mice (41).
In nasal, cutaneous, and corneal infection models, TLR2 deficiency is associated with higher bacterial loads and an increased disease severity (41) . However, TLR9-deficient mice did not show an impaired response to S. aureus corneal infection (41) . MyD88-and IL-1R-deficient mice were more susceptible to S. aureus infection than TLR2-deficient mice (42) , suggesting that other family members contribute to IL-1R/TLR signaling.
TLR5 has a dual role in host defense against microbial infection in terms of infection route and infectious dose (43) . TLR5-deficient mice exhibited increased susceptibility to urinary tract infection with Escherichia coli, and increased inflammation in the bladder and kidneys (44) . TLR5 contributes to protection after systemic infection with S. typhimurium and intranasal infection with Pseudomonas aeruginosa, although this can be masked by TLR4 and other flagellin-sensing pathways (45) . In contrast, a deleterious role for TLR5, which is mainly expressed on intestinal CD11c+ lamina propria cells, was reported in mice orally infected with S. typhimurium (46) . In this study, susceptibility and survival were dependent on the transport of 
Negative regulators in TLR signaling
TLR signaling pathways are tightly controlled to prevent excessive and uncontrolled inflammatory responses that often lead to deleterious pathogenesis with an increased mortality rate. In TLR signaling, several negative regulators that function through the prevention of ligand-receptor binding, degradation of the target protein, and inhibition of recruitment or transcription of intermediates, have been identified. We will briefly discuss several key regulators of TLR signaling (Fig. 2) . In one study, IRAKM-deficient macrophages markedly enhanced the production of inflammatory responses to bacterial infection and reduced tolerance in response to endotoxin (65) . The mechanisms by which IRAKM regulates TLR signaling are involved in the dissociation of the IRAK1 and IRAK4 complex from MyD88, thereby preventing formation of the IRAK1-TRAF6 complex (65) . A20 is one of the best-characterized negative regulators of TLR signaling. A20 was initially reported to be a TNF-induced novel zinc-finger protein that inhibits TNF-induced NF-κB activation (66, 67) . Further research revealed that A20 is an inducible cysteine protease de-ubiquitinylating enzyme that removes ubiquitin moieties from TRAF6 to terminate TLR signaling in both the MyD88-dependent and MyD88-independent TLR-signaling pathways (68) . A20 regulates the production of inflammatory cytokines in response to TLR2, 3, and 9 ligands, and modulates the development of endotoxin-induced lethal shock (68) . 
